FdaApplication
NDA 020835
Identifiers
- fda_app_no: NDA020835
Properties
| Property | Value |
|---|---|
| applicant_name | ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD |
| application_type | NDA |
| approval_date | 1998-03-27 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ACTONEL | RISEDRONATE SODIUM | 150MG | TABLET;ORAL |
| ACTONEL | RISEDRONATE SODIUM | 5MG | TABLET;ORAL |
| ACTONEL | RISEDRONATE SODIUM | 30MG | TABLET;ORAL |
| ACTONEL | RISEDRONATE SODIUM | 35MG | TABLET;ORAL |
| ACTONEL | RISEDRONATE SODIUM | 75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
5 products